Comparison of Dexmedetomidine and Midazolam as Intanasal Premedication in Childre
- Conditions
- Health Condition 1: null- Children aged 2-10 years undergoing minor surgical procedures under general anaesthesiaHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2018/03/012807
- Lead Sponsor
- Principle Investigator
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 104
Children aged 2-10 years undergoing minor surgical procedures under general anaesthesia
American Society of Anaestheiologists (ASA) Physical Status I & II grade of patients.
Parent refusal
Known allergy to the drugs under study.
Cardiac dysrhythmias and/or congenital heart disease
Psychotropic medication use
Mental retardation
Nasal disorders interfering with administration of medication as recurrent nasal bleeding or nasal masses.
Children who spat or refused intranasal administration of medication.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Modified observer�s Assessment of Alertness/Sedation scale (MOAA/S). <br/ ><br>Parental Separation Anxiety scale (PSAS). <br/ ><br>Mask Acceptance Score(MAS).Timepoint: Modified observer�s Assessment of Alertness/Sedation scale (MOAA/S). 30 minutes. <br/ ><br>Parental Separation Anxiety scale (PSAS). 30 minutes. <br/ ><br>Mask Acceptance Score(MAS). 30 minutes.
- Secondary Outcome Measures
Name Time Method pulse rate, BP, respiratory rate and oxygen saturation were recorded every 10 minute interval for 30 minutes from the time of extubationTimepoint: pulse rate, BP, respiratory rate and oxygen saturation were recorded every 10 minute interval for 30 minutes from the time of extubation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.